BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RSS0393 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of RSS0393\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07543224-1475@assetmemo.bio
DTSTAMP:20261121T004009Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:RSS0393: Phase 3 readout est. (NCT07543224)
DESCRIPTION:RSS0393\, phase 3\, Psoriasis.\nStudy: A Multicenter\, Randomiz
 ed\, Double-Blind\, Placebo-Controlled Phase III Clinical Study to Evaluat
 e the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaqu
 e Psoriasis.\nEstimated primary completion: January 2027. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/rss0393#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07543224
URL:https://assetmemo.bio/drug/rss0393#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
